REGENXBIO (RGNX) Tmuɣli n wazal

REGENXBIO

Healthcare · USD · United States of America

TG WA X in ⧉

Ṛṛbem n lḥedd$7.38Yettwalemmaḍ 25 Sep 2026 19:59 UTC

Beddel+1.93%

Asnulfu n AI: RGNX

1 wass

$7.38

🔒 Serreḥ Premium

1 yimal

$7.38

🔒 Serreḥ Premium

1 aggay

$7.38

🔒 Serreḥ Premium

AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.

Asref n 6 isggʷasn ineggura

Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.

Serreḥ Premium

🔒 Tazmilt n usenfar

Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.

Serreḥ Premium

Ɣef tneɣlaft-a

REGENXBIO Inc. is a biotechnology company that specializes in the development, commercialization, and licensing of recombinant adeno-associated virus-based gene therapy technologies.

Isṭok icudden ɣer

TXG10X Genomics Inc Ṛṛbem n lḥedd$85.71 +1.90%Asnulfu n AI · 1 wass🔒 Premium ABTAbbott Ṛṛbem n lḥedd$101.31 +0.24%Asnulfu n AI · 1 wass🔒 Premium ABBVAbbVie Ṛṛbem n lḥedd$264.31 -0.31%Asnulfu n AI · 1 wass🔒 Premium ABCLAbCellera Biologics Ṛṛbem n lḥedd$12.72 +0.47%Asnulfu n AI · 1 wass🔒 Premium ACADACADIA Pharmaceuticals Inc Ṛṛbem n lḥedd$20.68 -6.76%Asnulfu n AI · 1 wass🔒 Premium ACMRACM Research Inc Ṛṛbem n lḥedd$77.34 +1.52%Asnulfu n AI · 1 wass🔒 Premium ADAPAdaptimmune Therapeutics АДР Ṛṛbem n lḥedd$0.03 +50.00%Asnulfu n AI · 1 wass🔒 Premium ADPTAdaptive Biotechnologies Ṛṛbem n lḥedd$29.45 -0.41%Asnulfu n AI · 1 wass🔒 Premium

Aweḍ isenfal n AI Stock Predictions tura

Sider aselkim-nneɣ i yisenfal n isehnan n AI ɣef iPhone, Android d Windows

Serreḥ Premium

Tasnayt: Isenfal n isehnan n AI ttawin-d talɣut kan, ur d-qqaren ara ameslay n tedrimt. Aḍris n uẓri ur yeqqin ara i yigmaḍ n lwaqt. Ssned s tmeslayt-k s tufat, ssewḥed akked yiwen n umeslay n tedrimt n lqayed qbel n tteḥdid n tneflit. Tneflit tesɛa aḍris, akked tḍeyyeɛ n wazal.